Thiol modification of bevacizumab, an anti-VEGF monoclonal antibody: labeling with Technetium-99m and initial in vitro and in vivo studies

Bouziotis, P; Gourni, E; Harris, AL; Loudos, G; Sakellios, N; Livaniou, E; Paravatou, M; Xanthopoulos, S; Archimandritis, S; Varvarigou, AD

dc.contributor.author	Bouziotis, P	en
dc.contributor.author	Gourni, E	en
dc.contributor.author	Harris, AL	en
dc.contributor.author	Loudos, G	en
dc.contributor.author	Sakellios, N	en
dc.contributor.author	Livaniou, E	en
dc.contributor.author	Paravatou, M	en
dc.contributor.author	Xanthopoulos, S	en
dc.contributor.author	Archimandritis, S	en
dc.contributor.author	Varvarigou, AD	en
dc.date.accessioned	2014-03-01T11:46:19Z
dc.date.available	2014-03-01T11:46:19Z
dc.date.issued	2007	en
dc.identifier.issn	1619-7070	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/37802
dc.subject.classification	Radiology, Nuclear Medicine & Medical Imaging	en
dc.title	Thiol modification of bevacizumab, an anti-VEGF monoclonal antibody: labeling with Technetium-99m and initial in vitro and in vivo studies	en
heal.type	other	en
heal.language	English	en
heal.publicationDate	2007	en
heal.publisher	SPRINGER	en
heal.journalName	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING	en
dc.identifier.isi	ISI:000253283900675	en
dc.identifier.volume	34	en
dc.identifier.spage	S260	en
dc.identifier.epage	S260	en